FRATES JAMES M

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 78% 68% 82%
Transactions
8 12% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 411%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
FRATES JAMES M's trades of Amylyx Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
33.60
Quantity 32,500
Value US$1,092,000
Transaction date
Planned sale
Price
162.22
Quantity 8,000 -65.4%
Value US$1,297,760
Transaction date
Planned sale
Price
134.81
Quantity 7,500 -63.9%
Value US$1,011,075
US Alkermes Plc (ALKS)
Transaction date
Planned sale
Price
13.41
Quantity 2,174 -4.8%
Value US$29,157
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-14 2026-09-10
S Sale
9,204 +46.8%
468.95
US$3,962,919 		9,204 +46.8% 468.95 US$3,962,919
2026-09-14 2026-09-10
S Sale
69,233 -4.7%
342.53
US$946,981 		69,233 -4.7% 342.53 US$946,981
2026-09-11 2026-09-10
PrS Proposed sale
28,384
105.17
US$3,457,661 		28,384 105.17 US$3,457,661
2026-03-04 2026-03-02
S Sale
7,909 -4.6%
14.52
US$114,851 		7,909 -4.6% 14.52 US$114,851
2026-03-02 2026-03-02
PrS Proposed sale
7,909
14.52
US$114,852 		7,909 14.52 US$114,852
2026-02-04 2026-02-02
S Sale
3,557 -2.0%
14.65
US$52,097 		3,557 -2.0% 14.65 US$52,097
2026-02-02 2026-02-02
PrS Proposed sale
3,557
14.65
US$52,097 		3,557 14.65 US$52,097
2026-01-08 2026-01-06
S Sale
3,326 -1.8%
11.11
US$36,954 		3,326 -1.8% 11.11 US$36,954
2026-01-06 2026-01-06
PrS Proposed sale
3,326
11.11
US$36,954 		3,326 11.11 US$36,954
2025-10-02 2025-09-30
S Sale
10,558 -3.6%
14.65
US$154,650 		10,558 -3.6% 14.65 US$154,650
2025-04-02 2025-03-31
S Sale
10,896 -3.6%
3.47
US$37,806 		10,896 -3.6% 3.47 US$37,806
2024-09-16 2024-09-12
B Purchase
40,000 +20.7%
2.53
US$101,368 		40,000 +20.7% 2.53 US$101,368
2024-03-07 2024-03-05
S Sale
1,792 -1.3%
18.73
US$33,560 		1,792 -1.3% 18.73 US$33,560
2024-01-11 2024-01-09
S Sale
2,716 -2.4%
16.33
US$44,347 		2,716 -2.4% 16.33 US$44,347
2023-05-18 2023-05-16
PlS Planned sale
500 -0.9%
27.60
US$13,800 		500 -0.9% 27.60 US$13,800
2023-05-18 2023-05-16
PlS Planned sale
32,000 -36.3%
26.93
US$861,651 		32,000 -36.3% 26.93 US$861,651
2023-05-16 2023-05-16
PrS Proposed sale
32,500
28.14
US$914,550 		32,500 28.14 US$914,550
2023-03-20 2023-03-16
PlS Planned sale
1,704 -53.0%
32.46
US$55,320 		1,704 -53.0% 32.46 US$55,320
2023-03-20 2023-03-16
PlS Planned sale
30,796 -90.6%
31.86
US$981,139 		30,796 -90.6% 31.86 US$981,139
2023-03-16 2023-03-16
PrS Proposed sale
32,500
33.60
US$1,092,000 		32,500 33.60 US$1,092,000
2019-05-06 2019-05-06
PlS Planned sale
8,000 -65.4%
162.22
US$1,297,760 		8,000 -65.4% 162.22 US$1,297,760
2019-01-24 2019-01-23
PlS Planned sale
7,500 -63.9%
134.81
US$1,011,075 		7,500 -63.9% 134.81 US$1,011,075
2004-07-02 2004-07-01
US Alkermes Plc (ALKS)
PlS Planned sale
2,174 -4.8%
13.41
US$29,157 		2,174 -4.8% 13.41 US$29,157